The transplant, part of a three-person compassionate use study, used a pig kidney with 69 gene edits provided by US-based biotech eGenesis. The company received the go-ahead from the US Food and ...

On a 300-acre farm in an undisclosed location in rural Wisconsin, surrounded by fields dotted with big red barns and bordered ...

The US FDA has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in cross-species transplantation.

David-Alexandre C. Gros, MD, CEO of Eledon Pharmaceuticals, is overjoyed to learn that the second patient to receive a genetically modified pig kidney developed by eGenesis has been released from ...

BioAge plans to list on the Nasdaq under the symbol BIOA. Topping the list of recent private rounds is eGenesis, a developer of transplant organs from pigs designed to be compatible with humans ...

Egenesis, a startup that raised $38 million in March, just successfully used the gene-editing tool CRISPR to knock out a key virus in piglets. The virus-free pigs could get us a step closer to ...

The original genetically modified pig was produced by U.S. biotechnology company eGenesis. In September 2023, PorMedTec received cells from the pig and produced cloned fertilized eggs.

The biotech company United Therapeutics plans to include up to 50 people in the study this summer; the second company involved is eGenesis.

Two biotechnology companies, United Therapeutics Corporation and eGenesis, have been cleared to begin their studies this year. If successful, these trials could revolutionize organ transplantation ...